Journals / Cukurova Medical Journal / 2020 / Cilt: 45 - Sayı: 4

Oxidative stress markers in liver in streptozocin-induced diabetic rats: effects of metformin and sitagliptin

Streptozotosin kaynaklı diyabetik sıçanların karaciğerindeki oksidatif stres belirteçleri: metformin ve sitagliptinin etkileri

Pages
1733–1741
Publication Date
2020-12-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In the experimental T2D model in rats, it shows protective effect when sitagliptin is used with metformin against oxidative damage in liver tissue caused by STZ.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: This study aims at investigating the oxidative stress effect of antidiabetic drugs of Metformin (MET) and sitagliptin (STG) in the liver tissue of diabetic rats from streptozotocin (STZ).
📊
Key Findings & Data:Materials and Methods: Thirty-five female Wistar rats (3-4 months old, weighing 200±25 g) were divided into five groups (with seven rats each) and treated as follows: control (Cont), streptozotocin alone (STZ), streptozotocin + metformin (STZ+MET), streptozotocin + sitagliptin (STZ+STG), streptozotocin + metformin + sitagliptin (STZ+MET+STG).
💡
Conclusion & Impact:Conclusion: In the experimental T2D model in rats, it shows protective effect when sitagliptin is used with metformin against oxidative damage in liver tissue caused by STZ.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:metformin · sitagliptin · oxidative stress

Abstract

Purpose: This study aims at investigating the oxidative stress effect of antidiabetic drugs of Metformin (MET) and sitagliptin (STG) in the liver tissue of diabetic rats from streptozotocin (STZ). Materials and Methods: Thirty-five female Wistar rats (3-4 months old, weighing 200±25 g) were divided into five groups (with seven rats each) and treated as follows: control (Cont), streptozotocin alone (STZ), streptozotocin + metformin (STZ+MET), streptozotocin + sitagliptin (STZ+STG), streptozotocin + metformin + sitagliptin (STZ+MET+STG). Sitagliptin, Metformin, and combined metformin sitagliptin treated subgroups for four weeks. Malondialdehyde (MDA), total antioxidant status (TAS), total oxidant status (TOS) levels, and oxidative stress index (OSI) ratio were measured in rat liver tissue. Besides, cells undergoing apoptotic cell death were determined using the TUNEL technique through histopathological evaluation. Results: MDA, TAS, and OSI of STZ+MET+STG administered group decreased compared to STZ. TOS of STZ+MET+STG administered group decreased compared to STZ. Conclusion: In the experimental T2D model in rats, it shows protective effect when sitagliptin is used with metformin against oxidative damage in liver tissue caused by STZ.

Özet

Amaç: Bu çalışmanın amacı, streptozotosin (STZ) kaynaklı diyabetik sıçanların karaciğer dokusunda metformin (MET) ve/veya sitagliptinin (STG) antidiyabetik ilaçların olası oksidatif stres etkisini araştırmaktır. Gereç ve Yöntem: Bu çalışmada erişkin dişi Wistar albino sıçanları kullanılmış ve rastgele kontrol normal grubu, kontrol diyabetik grubu ve diyabetik gruba ayrılmıştır. Antidiyabetik ilaç grubuna sahip diyabetik sıçanlar aşağıdaki tedavi edilen alt gruplara ayrıldı: Sitagliptin (10 mg/ kg/ gün), Metformin (200mg/ kg/ gün) ve Kombine metformin sitagliptin ile 4 hafta boyunca tedavi edilen alt gruplar. Sıçan karaciğer dokusunda oksidatif stres belirteçleri (Malondialdehid (MDA), total antioksidan durum (TAS), total oksidan durum (TOS) ve oksidatif stres indeksi (OSI) seviyeleri) ölçüldü. Ek olarak, apoptotik hücre ölümü geçiren hücreler histopatolojik değerlendirme ile TUNEL tekniği kullanılarak belirlendi. Bulgular: STZ + MET + STG uygulanan grubun MDA, TAS ve OSI'si STZ'ye göre azaldı. STZ + MET + STG uygulanan grubun TOS'u STZ'ye göre azaldı. Sonuç: Sıçanlarda deneysel T2D modelinde, sitagliptin metformin ile birlikte kullanıldığında karaciğer dokusunda STZ'nin neden olduğu oksidatif hasara karşı koruyucu etki göstermektedir.

🔖

Cite This Article

ÇAKINA, S., ÖZTÜRK, Ş. (2020). Oxidative stress markers in liver in streptozocin-induced diabetic rats: effects of metformin and sitagliptin. Cukurova Medical Journal, Cilt: 45 - Sayı: 4, 1733–1741. https://ajindex.com/articles/101944

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Mohamed J, Nazratun Nafizah AH, Zariyantey AH, Budin SB. Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation. Sultan Qaboos Univ Med J. 2016;16:132-41
  2. Shawky LM, Morsi AA, El Bana E, Hanafy SM. The biological impacts of sitagliptin on the pancreas of a rat model of type 2 diabetes mellitus: drug interactions with metformin. Biology (Basel). 2019;9:6
  3. Alam MM, Ahmad I, Naseem I. Inhibitory effect of quercetin in the formation of advance glycation end products of human serum albumin: An in vitro and molecular interaction study. Int J Biol Macromol. 2015;79:336-43
  4. Eitah HE, Maklad YA, Abdelkader NF, Gamal El Din AA, Badawi MA, Kenawy SA. Modulating impacts of quercetin/sitagliptin combination on streptozotocin- induced diabetes mellitus in rats. Toxicol Appl Pharmacol. 2019;365:30-40
  5. Baig NA, Herrine SK, Rubin R. Liver disease and diabetes mellitus. Clin Lab Med. 2001;21:193-207
  6. Asmat U, Abad K, Ismail K. Diabetes mellitus and oxidative stress: A concise review. Saudi Pharm J. 2016;24:547-53
  7. Bansal AK, Bilaspuri GS. Impacts of oxidative stress and antioxidants on semen functions. Vet Med Int. 2010;2010:686137
  8. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5:9-19
  9. Hostalek U, Gwilt M, Hildemann S. therapeutic use of metformin in prediabetes and diabetes prevention. Drugs. 2015;75:1071-94
  10. Algire C, Moiseeva O, Deschênes-Simard X, Amrein L, Petruccelli L, Birman E et al. Metformin reduces endogenous reactive oxygen species and associated DNA damage. Cancer Prev Res (Phila). 2012;5:536- 43
  11. Carvalho C, Correia S, Santos M, Seiça R, Oliveira C, Moreira P. Metformin promotes isolated rat liver mitochondria impairment. Mol Cel Biochem. 2008;308:75-83
  12. Kelly B, Tannahill GM, Murphy MP, O'Neill LA. Metformin inhibits the production of reactive oxygen species from NADH:ubiquinone oxidoreductase to limit induction of interleukin-1β (IL-1β) and Boosts Interleukin-10 (IL-10) in lipopolysaccharide (LPS)- activated macrophages. J Biol Chem. 2015;290:20348- 59
  13. Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J. 2000;348:607-14
  14. Chen YT, Tsai TH, Yang CC, Sun CK, Chang LT, Chen HH et al. Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidativ